Praxis Precision Medicines shares insights on its drug pipeline and commercial strategy during Investor Day, emphasizing growth in the pharmaceutical sector.
| Name | Praxis Precision Medicines, Inc. |
|---|---|
| CIK | 0001689548 |
| Tickers | PRAX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-300-8460 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Praxis Precision Medicines shares insights on its drug pipeline and commercial strategy during Investor Day, emphasizing growth in the pharmaceutical sector.
Praxis Precision Medicines, Inc. releases its Q3 2026 report, detailing financial performance and updates on drug development in the pharmaceutical sector.
Praxis Precision Medicines announces Q3 2026 financial results, highlighting key regulatory milestones and plans for new CNS therapies.
FMR LLC now holds 9.2% of Praxis Precision Medicines, reflecting growing interest in the pharmaceutical preparations sector.
519 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 4 | FORM 4 | 0001689548-26-000095 | 4943 | ||||||
| 2026-11-18 | 4 | FORM 4 | 0001689548-26-000094 | 4926 | ||||||
| 2026-11-18 | 4 | FORM 4 | 0001689548-26-000093 | 4948 | ||||||
| 2026-11-18 | 4 | FORM 4 | 0001689548-26-000092 | 4954 | ||||||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000940594-26-000076 | 005-92098 | 261557668 | 34 | 10667 | |||
| 2026-11-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-26-000091 | 001-39620 | 261547982 | 34 | 20070129 | 1 | 1 |
| 2026-11-09 | 10-Q | 10-Q | 0001689548-26-000089 | 001-39620 | 261536502 | 34 | 5991370 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001689548-26-000086 | 001-39620 | 261533765 | 34 | 260284 | 1 | 1 |
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002828 | 005-92098 | 261526282 | 34 | 11692 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000940594-26-000055 | 005-92098 | 261279749 | 34 | 10596 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001689548-26-000083 | 001-39620 | 261246248 | 34 | 5861372 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-26-000082 | 001-39620 | 261246240 | 34 | 5842307 | 1 | 1 |
| 2026-07-08 | 4 | FORM 4 | 0001707657-26-000008 | 6358 | ||||||
| 2026-07-07 | 8-K | 8-K | 8.01 | 0001689548-26-000072 | 001-39620 | 261160027 | 34 | 148275 | 1 | 1 |
| 2026-07-02 | 8-K | FORM 8-K | 4.01,9.01 | 0001104659-26-080356 | 001-39620 | 261151841 | 34 | 200353 | 1 | 1 |
| 2026-06-29 | 8-K | 8-K | 8.01 | 0001689548-26-000069 | 001-39620 | 261136369 | 34 | 148544 | 1 | 1 |
| 2026-06-26 | 4 | FORM 4 | 0001930479-26-000003 | 32418 | ||||||
| 2026-06-24 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004864 | 001-39620 | 261116109 | 33 | 4383 | |||
| 2026-06-22 | 8-K | 8-K | 8.01 | 0001689548-26-000066 | 001-39620 | 261107667 | 34 | 146173 | 1 | 1 |
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000064 | 7578 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000063 | 7597 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000062 | 7533 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000061 | 7579 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000060 | 7597 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000059 | 7563 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000058 | 7749 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001689548-26-000057 | 7520 | ||||||
| 2026-06-12 | 8-K | 8-K | 5.07 | 0001689548-26-000056 | 001-39620 | 261087546 | 34 | 159719 | 1 | 1 |
| 2026-06-01 | 8-K | 8-K | 8.01 | 0001689548-26-000053 | 001-39620 | 261051315 | 34 | 148373 | 1 | 1 |
| 2026-05-19 | 4 | FORM 4 | 0001827639-26-000007 | 4956 | ||||||
| 2026-05-19 | 4 | FORM 4 | 0001827760-26-000007 | 4927 | ||||||
| 2026-05-19 | 4 | FORM 4 | 0001689548-26-000050 | 4951 | ||||||
| 2026-05-19 | 4 | FORM 4 | 0001781480-26-000008 | 4908 | ||||||
| 2026-05-19 | 4 | FORM 4 | 0001707657-26-000005 | 5619 | ||||||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062582 | 005-92098 | 26987890 | 34 | 19965 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003465 | 005-92098 | 26987760 | 34 | 17115 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000940594-26-000038 | 005-92098 | 26985196 | 34 | 10595 | |||
| 2026-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-26-000049 | 001-39620 | 26973530 | 34 | 5778281 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001689548-26-000047 | 001-39620 | 26951174 | 34 | 5354687 | 1 | 1 | |
| 2026-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001292 | 005-92098 | 26946942 | 34 | 11311 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001689548-26-000040 | 001-39620 | 26925723 | 34 | 1343761 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001689548-26-000039 | 001-39620 | 26925630 | 34 | 5568909 | 1 | 1 | |
| 2026-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000894 | 005-92098 | 26921842 | 34 | 7380 | |||
| 2026-04-14 | 8-K | 8-K | 8.01 | 0001689548-26-000033 | 001-39620 | 26861602 | 34 | 145472 | 1 | 1 |
| 2026-04-06 | 8-K | 8-K | 8.01 | 0001689548-26-000031 | 001-39620 | 26841509 | 34 | 151406 | 1 | 1 |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002052 | 005-92098 | 26802906 | 34 | 7145 | |||
| 2026-02-19 | S-8 | FORM S-8 | 0001104659-26-017306 | 333-293567 | 26651675 | 33 | 256770 | 1 | 1 | |
| 2026-02-19 | 10-K | 10-K | 0001689548-26-000029 | 001-39620 | 26651561 | 34 | 11197574 | 1 | 1 | |
| 2026-02-19 | 8-K | 8-K | 2.02,9.01 | 0001689548-26-000028 | 001-39620 | 26651559 | 34 | 273315 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001140 | 005-92098 | 26642261 | 34 | 17854 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-26-054527 | 005-92098 | 26640557 | 34 | 10514 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000940594-26-000016 | 005-92098 | 26638630 | 34 | 16407 | |||
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-000917 | 005-92098 | 26623725 | 34 | 12373 | |||
| 2026-02-10 | 4 | FORM 4 | 0001689548-26-000018 | 9323 | ||||||
| 2026-02-10 | 4 | FORM 4 | 0001689548-26-000017 | 9493 | ||||||
| 2026-02-10 | 8-K/A | 8-K/A | 5.02,9.01 | 0001689548-26-000016 | 001-39620 | 26616878 | 34 | 195967 | 1 | 1 |
| 2026-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000505 | 005-92098 | 26602015 | 34 | 11356 | |||
| 2026-01-13 | 4 | FORM 4 | 0001827639-26-000005 | 4800 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001781480-26-000006 | 4753 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001827760-26-000005 | 4772 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001863297-26-000005 | 4795 | ||||||
| 2026-01-12 | 4 | FORM 4 | 0001689548-26-000014 | 9064 | ||||||
| 2026-01-12 | 4 | FORM 4 | 0001689548-26-000013 | 9014 | ||||||
| 2026-01-12 | 4 | FORM 4 | 0001689548-26-000012 | 9034 | ||||||
| 2026-01-12 | 4 | FORM 4 | 0001689548-26-000011 | 9051 | ||||||
| 2026-01-12 | 4 | FORM 4 | 0001689548-26-000010 | 9724 | ||||||
| 2026-01-12 | 3 | FORM 3 | 0001689548-26-000009 | 368895 | ||||||
| 2026-01-12 | 3 | FORM 3 | 0001689548-26-000008 | 369096 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001827639-26-000002 | 4799 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001827760-26-000002 | 4771 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001863297-26-000002 | 4795 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001707657-26-000002 | 5463 | ||||||
| 2026-01-09 | 3 | FORM 3 | 0001689548-26-000007 | 376513 | ||||||
| 2026-01-08 | 8-K | 8-K | 5.02 | 0001689548-26-000005 | 001-39620 | 26520366 | 34 | 155630 | 1 | 1 |
| 2026-01-07 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-26-001825 | 001-39620 | 26516621 | 34 | 559279 | 1 | 1 |
| 2026-01-07 | 424B5 | 424B5 | 0001104659-26-001823 | 333-284016 | 26516608 | 33 | 704166 | 1 | 1 | |
| 2026-01-06 | 8-K | 8-K | 2.02 | 0001689548-26-000002 | 001-39620 | 26511905 | 34 | 149828 | 1 | 1 |
| 2026-01-06 | 424B5 | 424B5 | 0001104659-26-001307 | 333-284016 | 26511623 | 33 | 620027 | |||
| 2025-12-31 | 4 | FORM 4 | 0001707657-25-000004 | 5356 | ||||||
| 2025-12-29 | 8-K | 8-K | 8.01 | 0001689548-25-000118 | 001-39620 | 251603174 | 34 | 145525 | 1 | 1 |
| 2025-12-11 | 8-K | 8-K | 8.01 | 0001689548-25-000116 | 001-39620 | 251565295 | 34 | 151073 | 1 | 1 |
| 2025-12-08 | 8-K | 8-K | 8.01 | 0001689548-25-000114 | 001-39620 | 251556325 | 34 | 157659 | 1 | 1 |
| 2025-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-115100 | 4908 | ||||||
| 2025-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-115099 | 29496 | ||||||
| 2025-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-115098 | 33769 | ||||||
| 2025-11-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007151 | 001-39620 | 251501769 | 33 | 5882 | |||
| 2025-11-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007150 | 001-39620 | 251501746 | 33 | 6958 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004979 | 005-92098 | 251485467 | 34 | 18164 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004950 | 005-92098 | 251483854 | 34 | 10433 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000080255-25-000837 | 005-92098 | 251483455 | 34 | 7674 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000284 | 005-92098 | 251483155 | 34 | 10667 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000579 | 005-92098 | 251461732 | 34 | 12245 | |||
| 2025-11-05 | 10-Q | 10-Q | 0001689548-25-000111 | 001-39620 | 251451882 | 34 | 5757861 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001689548-25-000110 | 001-39620 | 251451877 | 34 | 269271 | 1 | 1 |
| 2025-11-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004715 | 005-92098 | 251444177 | 34 | 12553 | |||
| 2025-10-21 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-25-000103 | 001-39620 | 251405392 | 34 | 9185121 | 1 | 1 |
| 2025-10-20 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-100488 | 001-39620 | 251401812 | 34 | 777274 | 1 | 1 |
| 2025-10-20 | 424B5 | 424B5 | 0001104659-25-100487 | 333-284016 | 251401808 | 33 | 832383 | 1 | 1 | |
| 2025-10-17 | 4 | xslF345X05/ownership.xml | 0000902664-25-004455 | 28907 | ||||||
| 2025-10-16 | 424B5 | 424B5 | 0001104659-25-100136 | 333-284016 | 251398317 | 33 | 666769 | |||
| 2025-10-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-25-000100 | 001-39620 | 251396400 | 34 | 4292048 | 1 | 1 |
| 2025-09-25 | 4 | FORM 4 | 0001689548-25-000096 | 13547 | ||||||
| 2025-09-05 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-087865 | 001-39620 | 251297281 | 34 | 510648 | 1 | 1 |
| 2025-09-05 | 424B5 | 424B5 | 0001104659-25-087861 | 333-284016 | 251297257 | 33 | 581442 | 1 | 1 | |
| 2025-09-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003938 | 005-92098 | 251285463 | 34 | 12365 | |||
| 2025-08-19 | 3 | xslF345X02/ownership.xml | 0000902664-25-003755 | 8047 | ||||||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003695 | 005-92098 | 251220711 | 34 | 18158 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003434 | 005-92098 | 251217851 | 34 | 10867 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000212 | 005-92098 | 251215583 | 34 | 10667 | |||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003499 | 005-92098 | 251204324 | 34 | 12361 | |||
| 2025-08-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-072152 | 005-92098 | 251185943 | 34 | 19623 | |||
| 2025-08-04 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-25-000094 | 001-39620 | 251178277 | 34 | 3751314 | 1 | 1 |
| 2025-08-04 | 10-Q | 10-Q | 0001689548-25-000092 | 001-39620 | 251178212 | 34 | 5602676 | 1 | 1 | |
| 2025-07-22 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-097436 | 005-92098 | 251138934 | 34 | 19881 | |||
| 2025-07-17 | 8-K | 8-K | 7.01,8.01 | 0001689548-25-000086 | 001-39620 | 251128854 | 34 | 149814 | 1 | 1 |
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000081 | 5284 | ||||||
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000080 | 5258 | ||||||
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000079 | 5244 | ||||||
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000078 | 5301 | ||||||
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000077 | 5316 | ||||||
| 2025-06-27 | 4 | FORM 4 | 0001689548-25-000076 | 5318 | ||||||
| 2025-06-27 | 8-K | 8-K | 5.07 | 0001689548-25-000075 | 001-39620 | 251087151 | 34 | 159813 | 1 | 1 |
| 2025-06-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000185 | 005-92098 | 251029588 | 34 | 10667 | |||
| 2025-05-19 | 4 | FORM 4 | 0001689548-25-000066 | 5480 | ||||||
| 2025-05-19 | 4 | FORM 4 | 0001689548-25-000065 | 4812 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-013262 | 005-92098 | 25956174 | 34 | 24874 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002432 | 005-92098 | 25954340 | 34 | 20485 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072732 | 005-92098 | 25954076 | 34 | 10524 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002195 | 005-92098 | 25951707 | 34 | 10747 | |||
| 2025-05-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000119 | 005-92098 | 25943751 | 34 | 9388 | |||
| 2025-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001422848-25-000078 | 005-92098 | 25938171 | 34 | 7429 | |||
| 2025-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002244 | 005-92098 | 25932864 | 34 | 15671 | |||
| 2025-05-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-25-000062 | 001-39620 | 25909889 | 34 | 6789901 | 1 | 1 |
| 2025-05-02 | 10-Q | 10-Q | 0001689548-25-000058 | 001-39620 | 25905612 | 34 | 5140403 | 1 | 1 | |
| 2025-05-02 | 8-K | 8-K | 2.02,9.01 | 0001689548-25-000056 | 001-39620 | 25905606 | 34 | 259968 | 1 | 1 |
| 2025-04-30 | DEFA14A | DEFA14A | 0001689548-25-000051 | 001-39620 | 25895784 | 34 | 1321826 | |||
| 2025-04-30 | DEF 14A | DEF 14A | 0001689548-25-000050 | 001-39620 | 25895739 | 34 | 3964807 | 1 | 1 | |
| 2025-03-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-025135 | 005-92098 | 25753551 | 34 | 30013 | |||
| 2025-02-28 | S-8 | FORM S-8 | 0001104659-25-018742 | 333-285398 | 25682971 | 33 | 228586 | 1 | 1 | |
| 2025-02-28 | S-8 | FORM S-8 | 0001104659-25-018741 | 333-285397 | 25682960 | 33 | 210172 | 1 | 1 | |
| 2025-02-28 | 10-K | 10-K | 0001689548-25-000040 | 001-39620 | 25682809 | 34 | 9267158 | 1 | 1 | |
| 2025-02-28 | 8-K | 8-K | 2.02,9.01 | 0001689548-25-000037 | 001-39620 | 25682803 | 34 | 268023 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-004233 | 005-92098 | 25631555 | 34 | 24902 | |||
| 2025-02-14 | 4 | FORM 4 | 0001689548-25-000027 | 4777 | ||||||
| 2025-02-14 | 4 | FORM 4 | 0001689548-25-000026 | 4805 | ||||||
| 2025-02-14 | 4 | FORM 4 | 0001689548-25-000025 | 5469 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021207 | 005-92098 | 25628897 | 34 | 10689 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-001036 | 005-92098 | 25628623 | 34 | 18392 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001099 | 005-92098 | 25627295 | 34 | 10777 | |||
| 2025-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000236 | 005-92098 | 25591266 | 34 | 11846 | |||
| 2025-01-29 | 8-K | 8-K | 2.02,9.01 | 0001689548-25-000021 | 001-39620 | 25570360 | 34 | 226740 | 1 | 1 |
| 2025-01-14 | 4 | FORM 4 | 0001689548-25-000016 | 9078 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001689548-25-000015 | 8138 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001689548-25-000014 | 9066 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001689548-25-000013 | 9050 | ||||||
| 2025-01-08 | 4 | FORM 4 | 0001689548-25-000008 | 5469 | ||||||
| 2025-01-08 | 4 | FORM 4 | 0001689548-25-000007 | 4804 | ||||||
| 2025-01-08 | 4 | FORM 4 | 0001689548-25-000006 | 4777 | ||||||
| 2025-01-08 | 4 | FORM 4 | 0001689548-25-000005 | 4801 | ||||||
| 2024-12-23 | S-3ASR | S-3ASR | 0001104659-24-131298 | 333-284016 | 241573758 | 33 | 1213302 | |||
| 2024-11-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-120748 | 4966 | ||||||
| 2024-11-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-120746 | 4962 | ||||||
| 2024-11-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-119844 | 9177 | ||||||
| 2024-11-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-119843 | 9205 | ||||||
| 2024-11-14 | SC 13G/A | p24-3173sc13ga.htm | 0000902664-24-006656 | 005-92098 | 241465313 | 34 | 104285 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119332 | 005-92098 | 241464786 | 34 | 157363 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119292 | 005-92098 | 241464726 | 34 | 88787 | |||
| 2024-11-14 | SC 13G/A | cormorant-prax093024a2.htm | 0001172661-24-005057 | 005-92098 | 241460786 | 34 | 87011 | |||
| 2024-11-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-007844 | 001-39620 | 241460466 | 33 | 4823 | |||
| 2024-11-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-007842 | 001-39620 | 241460057 | 33 | 5348 | |||
| 2024-11-14 | SC 13G | prax13gsep24.txt | 0000080255-24-001466 | 005-92098 | 34 | 6452 | ||||
| 2024-11-14 | SC 13G/A | sadaveritionpraxis_sc13ga1.htm | 0000905148-24-003080 | 005-92098 | 241457734 | 34 | 93912 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__PraxisPrec.txt | 0000932471-24-001134 | 005-92098 | 241449315 | 34 | 6537 | |||
| 2024-11-12 | SC 13G | SEC SCHEDULE 13G | 0001422848-24-000366 | 005-92098 | 241446543 | 34 | 18155 | |||
| 2024-11-12 | SC 13G/A | PRAXIS PRECISION MEDICINES, INC. | 0000902664-24-006413 | 005-92098 | 241444245 | 34 | 72079 | |||
| 2024-11-08 | SC 13G | us74006w2070_110824.txt | 0002012383-24-003391 | 005-92098 | 241439521 | 34 | 13818 | |||
| 2024-11-06 | 10-Q | 10-Q | 0001689548-24-000101 | 001-39620 | 241429280 | 34 | 5237506 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-24-000098 | 001-39620 | 241429278 | 34 | 7342108 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__PraxisPrec.txt | 0000932471-24-000630 | 005-92098 | 241422291 | 34 | 5586 | |||
| 2024-10-22 | SC 13G | us74006w2070_102224.txt | 0002012383-24-001244 | 005-92098 | 241386089 | 34 | 13806 | |||
| 2024-10-15 | 8-K | FORM 8-K | 5.02,9.01 | 0001104659-24-108345 | 001-39620 | 241369341 | 34 | 296449 | 1 | 1 |
| 2024-09-23 | SC 13G | SC 13G | 0001193125-24-223820 | 005-92098 | 241317180 | 34 | 63756 | |||
| 2024-09-03 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-24-096035 | 001-39620 | 241272087 | 34 | 9783806 | 1 | 1 |
| 2024-08-13 | 10-Q | 10-Q | 0001689548-24-000088 | 001-39620 | 241198773 | 34 | 5232078 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-24-000086 | 001-39620 | 241198768 | 34 | 6162955 | 1 | 1 |
| 2024-07-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-084506 | 5584 | ||||||
| 2024-07-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-084505 | 7592 | ||||||
| 2024-07-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-084504 | 7621 | ||||||
| 2024-07-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-084502 | 7616 | ||||||
| 2024-07-01 | SC 13G | SC 13G | 0001104659-24-077011 | 005-92098 | 241092746 | 34 | 88031 | |||
| 2024-06-10 | S-8 POS | FORM S-8 POS | 0001104659-24-070062 | 333-276786 | 241033524 | 33 | 115016 | |||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000079 | 5304 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000078 | 5287 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000077 | 5319 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000076 | 5321 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000075 | 5261 | ||||||
| 2024-06-06 | 4 | FORM 4 | 0001689548-24-000074 | 5289 | ||||||
| 2024-06-06 | 8-K | 8-K | 5.02,5.07,9.01 | 0001689548-24-000073 | 001-39620 | 241026370 | 34 | 324763 | 1 | 1 |
| 2024-05-20 | 4 | FORM 4 | 0001689548-24-000064 | 4818 | ||||||
| 2024-05-20 | 4 | FORM 4 | 0001689548-24-000063 | 5488 | ||||||
| 2024-05-13 | 10-Q | 10-Q | 0001689548-24-000060 | 001-39620 | 24937002 | 34 | 4765004 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,8.01,9.01 | 0001689548-24-000058 | 001-39620 | 24936998 | 34 | 257568 | 1 | 1 |
| 2024-04-26 | DEFA14A | DEFA14A | 0001689548-24-000049 | 001-39620 | 24878773 | 34 | 1349239 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001689548-24-000048 | 001-39620 | 24878760 | 34 | 2502846 | |||
| 2024-03-29 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-24-041158 | 001-39620 | 24804433 | 34 | 665472 | 1 | 1 |
| 2024-03-29 | 424B5 | 424B5 | 0001104659-24-041157 | 333-277656 | 24804406 | 33 | 621966 | |||
| 2024-03-27 | 424B5 | 424B5 | 0001104659-24-039744 | 333-277656 | 24791536 | 33 | 620159 | |||
| 2024-03-26 | 8-K | 8-K | 8.01 | 0001689548-24-000041 | 001-39620 | 24780870 | 34 | 164987 | 1 | 1 |
| 2024-03-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-03-12 16:00:00 | 9999999995-24-000649 | 333-277656 | 24744490 | 33 | 1742 | ||
| 2024-03-08 | CORRESP | filename1.htm | 0001104659-24-032476 | 8538 | ||||||
| 2024-03-08 | UPLOAD | filename1.pdf | 0000000000-24-002587 | 333-277656 | 40300 | |||||
| 2024-03-05 | S-3 | S-3 | 0001104659-24-030794 | 333-277656 | 24718460 | 33 | 1254083 | |||
| 2024-03-05 | S-8 | FORM S-8 | 0001104659-24-030762 | 333-277652 | 24718290 | 33 | 78824 | |||
| 2024-03-05 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-24-000035 | 001-39620 | 24718260 | 34 | 5690390 | 1 | 1 |
| 2024-03-05 | 10-K | 10-K | 0001689548-24-000034 | 001-39620 | 24718257 | 34 | 8670506 | 1 | 1 | |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024222 | 005-92098 | 24641687 | 34 | 150662 | |||
| 2024-02-14 | 4 | FORM 4 | 0001689548-24-000027 | 4800 | ||||||
| 2024-02-14 | SC 13G/A | p24-0502sc13ga.htm | 0000902664-24-001691 | 005-92098 | 24638232 | 34 | 97463 | |||
| 2024-02-14 | 4 | FORM 4 | 0001689548-24-000026 | 4772 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001689548-24-000025 | 4779 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023605 | 005-92098 | 24637908 | 34 | 113094 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0000929638-24-000650 | 005-92098 | 24636559 | 34 | 97326 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001580642-24-000986 | 005-92098 | 24634934 | 34 | 55973 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023117 | 005-92098 | 24633406 | 34 | 57111 | |||
| 2024-02-14 | SC 13G | SC 13G | 0001140361-24-007733 | 005-92098 | 24632723 | 34 | 89386 | |||
| 2024-02-13 | SC 13G/A | d10978747_13g-a.htm | 0000919574-24-001171 | 005-92098 | 24631026 | 34 | 192737 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-033803 | 005-92098 | 24626582 | 34 | 77456 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-030342 | 005-92098 | 24616235 | 34 | 143249 | |||
| 2024-02-07 | SC 13G/A | PRAXIS PRECISION MEDICINES, INC. | 0000902664-24-001176 | 005-92098 | 24602200 | 34 | 96072 | |||
| 2024-02-06 | SC 13G/A | d10943124_13g-a.htm | 0000919574-24-000689 | 005-92098 | 24601154 | 34 | 148260 | |||
| 2024-02-05 | SC 13G/A | SC 13G/A | 0001178913-24-000363 | 005-92098 | 24594214 | 34 | 95583 | |||
| 2024-01-31 | S-8 | FORM S-8 | 0001104659-24-008806 | 333-276786 | 24583187 | 33 | 273345 | |||
| 2024-01-17 | 4 | FORM 4 | 0001689548-24-000021 | 5663 | ||||||
| 2024-01-17 | 4 | FORM 4 | 0001689548-24-000020 | 5644 | ||||||
| 2024-01-17 | 4 | FORM 4 | 0001689548-24-000019 | 5636 | ||||||
| 2024-01-17 | 4 | FORM 4 | 0001689548-24-000018 | 5664 | ||||||
| 2024-01-12 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-24-003764 | 001-39620 | 24532926 | 34 | 668952 | 1 | 1 |
| 2024-01-12 | 424B5 | 424B5 | 0001104659-24-003763 | 333-260726 | 24532903 | 33 | 615401 | |||
| 2024-01-11 | 8-K | 8-K | 1.02 | 0001689548-24-000013 | 001-39620 | 24527905 | 34 | 159119 | 1 | 1 |
| 2024-01-10 | 424B5 | 424B5 | 0001104659-24-003034 | 333-260726 | 24527373 | 33 | 615682 | |||
| 2024-01-10 | 8-K | 8-K | 2.02,3.02,8.01 | 0001689548-24-000011 | 001-39620 | 24526708 | 34 | 168396 | 1 | 1 |
| 2024-01-09 | 4 | FORM 4 | 0001689548-24-000008 | 4952 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001689548-24-000007 | 4924 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001689548-24-000006 | 4931 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001689548-24-000005 | 4952 | ||||||
| 2023-12-07 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-23-124348 | 001-39620 | 231473370 | 34 | 530710 | 1 | 1 |
| 2023-12-07 | 424B5 | 424B5 | 0001104659-23-124344 | 333-260726 | 231473327 | 33 | 450168 | |||
| 2023-12-01 | 8-K | 8-K | 5.03,8.01,9.01 | 0001689548-23-000162 | 001-39620 | 231460026 | 34 | 264544 | 1 | 1 |
| 2023-11-22 | 8-K | FORM 8-K | 8.01 | 0001104659-23-120776 | 001-39620 | 231433885 | 34 | 203575 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0001689548-23-000159 | 001-39620 | 231381600 | 34 | 4384223 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001689548-23-000157 | 001-39620 | 231381594 | 34 | 262213 | 1 | 1 |
| 2023-11-06 | 8-K | 8-K | 5.07 | 0001689548-23-000150 | 001-39620 | 231380291 | 34 | 166391 | 1 | 1 |
| 2023-10-16 | DEF 14A | DEF 14A | 0001689548-23-000145 | 001-39620 | 231326195 | 34 | 730477 | |||
| 2023-10-10 | 4 | FORM 4 | 0001689548-23-000141 | 4404 | ||||||
| 2023-10-04 | PRE 14A | PRE 14A | 0001689548-23-000139 | 001-39620 | 231306587 | 34 | 730776 | |||
| 2023-10-02 | 8-K | 8-K | 8.01 | 0001689548-23-000133 | 001-39620 | 231298813 | 34 | 173938 | 1 | 1 |
| 2023-08-09 | 10-Q | 10-Q | 0001689548-23-000128 | 001-39620 | 231153509 | 34 | 4318005 | 1 | 1 | |
| 2023-08-09 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-23-000126 | 001-39620 | 231153488 | 34 | 7040528 | 1 | 1 |
| 2023-07-03 | SC 13G/A | schedule13g.htm | 0000929638-23-001891 | 005-92098 | 231065317 | 34 | 110365 | |||
| 2023-06-30 | SC 13G | PRAXIS PRECISION MEDICINES, INC. | 0000902664-23-003803 | 005-92098 | 231062461 | 34 | 99896 | |||
| 2023-06-30 | SC 13G | SC 13G | 0001104659-23-077120 | 005-92098 | 231061885 | 34 | 161553 | |||
| 2023-06-28 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-23-001600 | 005-92098 | 231052872 | 34 | 177335 | |||
| 2023-06-27 | 4 | FORM 4 | 0001689548-23-000115 | 5719 | ||||||
| 2023-06-27 | SC 13G/A | SC 13G/A | 0001178913-23-002298 | 005-92098 | 231044633 | 34 | 93926 | |||
| 2023-06-26 | SC 13G | PRAXIS PRECISION MEDICINES, INC. | 0000902664-23-003735 | 005-92098 | 231042753 | 34 | 117069 | |||
| 2023-06-22 | SC 13G | SC 13G | 0001178913-23-002270 | 005-92098 | 231032058 | 34 | 99989 | |||
| 2023-06-20 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-23-072550 | 001-39620 | 231023351 | 34 | 681606 | 1 | 1 |
| 2023-06-20 | 424B5 | 424B5 | 0001104659-23-072451 | 333-260726 | 231023207 | 33 | 585323 | |||
| 2023-06-16 | 8-K | 8-K | 1.02 | 0001689548-23-000113 | 001-39620 | 231019340 | 34 | 178304 | 1 | 1 |
| 2023-06-16 | FWP | FWP | 0001104659-23-071781 | 333-260726 | 231019221 | 34 | 46894 | |||
| 2023-06-15 | 424B5 | 424B5 | 0001104659-23-071683 | 333-260726 | 231018558 | 33 | 563014 | |||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000111 | 5311 | ||||||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000110 | 5326 | ||||||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000109 | 5268 | ||||||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000108 | 5328 | ||||||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000107 | 5296 | ||||||
| 2023-06-14 | 4 | FORM 4 | 0001689548-23-000106 | 5294 | ||||||
| 2023-06-14 | 8-K | 8-K | 5.07 | 0001689548-23-000105 | 001-39620 | 231012990 | 34 | 191757 | 1 | 1 |
| 2023-06-09 | 8-K | 8-K | 8.01 | 0001689548-23-000095 | 001-39620 | 231003852 | 34 | 181828 | 1 | 1 |
| 2023-06-08 | SC 13G/A | us74006w1080_060623.txt | 0001306550-23-009218 | 005-92098 | 231001416 | 34 | 12371 | |||
| 2023-06-05 | DEFA14A | DEFA14A | 0001104659-23-068018 | 001-39620 | 23992390 | 34 | 384090 | |||
| 2023-05-18 | 4 | FORM 4 | 0001689548-23-000092 | 4779 | ||||||
| 2023-05-18 | 4 | FORM 4 | 0001689548-23-000091 | 4752 | ||||||
| 2023-05-18 | 4 | FORM 4 | 0001689548-23-000090 | 4758 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0001689548-23-000086 | 001-39620 | 23908866 | 34 | 4046874 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-23-000084 | 001-39620 | 23908844 | 34 | 6677128 | 1 | 1 |
| 2023-04-28 | DEFA14A | DEFA14A | 0001689548-23-000074 | 001-39620 | 23866329 | 34 | 1225893 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001689548-23-000072 | 001-39620 | 23866150 | 34 | 2431674 | |||
| 2023-04-27 | SC 13G | SC 13G | 0001104659-23-051366 | 005-92098 | 23857232 | 34 | 66787 | |||
| 2023-04-17 | 8-K | 8-K | 7.01,9.01 | 0001689548-23-000062 | 001-39620 | 23822948 | 34 | 6500152 | 1 | 1 |
| 2023-04-06 | 4/A | OWNERSHIP DOCUMENT | 0001104659-23-042818 | 5322 | ||||||
| 2023-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-037023 | 7207 | ||||||
| 2023-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-037022 | 5050 | ||||||
| 2023-03-27 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-037021 | 5099 | ||||||
| 2023-03-21 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001104659-23-035170 | 001-39620 | 23750605 | 34 | 286410 | 1 | 1 |
| 2023-03-20 | SC 13D | SCHEDULE 13D | 0001193805-23-000359 | 005-92098 | 23745033 | 34 | 208915 | |||
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001689548-23-000059 | 001-39620 | 23724952 | 34 | 179083 | 1 | 1 |
| 2023-03-10 | SC 13G | SC 13G | 0001193125-23-067238 | 005-92098 | 23722645 | 34 | 96725 | |||
| 2023-03-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-23-000056 | 001-39620 | 23701641 | 34 | 5638889 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000377 | 005-92098 | 23629176 | 34 | 104531 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021576 | 005-92098 | 23628971 | 34 | 105984 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001580642-23-000865 | 005-92098 | 23626569 | 34 | 58757 | |||
| 2023-02-13 | 4 | FORM 4 | 0001689548-23-000051 | 4717 | ||||||
| 2023-02-13 | 4 | FORM 4 | 0001689548-23-000049 | 4700 | ||||||
| 2023-02-13 | 4 | FORM 4 | 0001689548-23-000048 | 4728 | ||||||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-032613 | 005-92098 | 23612134 | 34 | 48623 | |||
| 2023-02-09 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001104659-23-011530,2023-02-09 | 9999999995-23-000344 | 333-260726 | 23608384 | 33 | 1706 | ||
| 2023-02-09 | SC 13G/A | JHG PLC OWNS <5% | 0001274173-23-000021 | 005-92098 | 23605564 | 34 | 9996 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016756 | 005-92098 | 23604042 | 34 | 12966 | |||
| 2023-02-07 | S-8 | FORM S-8 | 0001104659-23-011536 | 333-269615 | 23592976 | 33 | 103509 | |||
| 2023-02-07 | POS AM | POS AM | 0001104659-23-011530 | 333-260726 | 23592961 | 33 | 808517 | |||
| 2023-02-07 | 10-K | 10-K | 0001689548-23-000044 | 001-39620 | 23592845 | 34 | 9860752 | 1 | 1 | |
| 2023-02-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-23-000043 | 001-39620 | 23592839 | 34 | 6585236 | 1 | 1 |
| 2023-02-07 | POSASR | POSASR | 0001104659-23-011502 | 333-260726 | 23592829 | 33 | 636137 | |||
| 2023-02-02 | SC 13G | d9931115_13g.htm | 0000919574-23-000666 | 005-92098 | 23580436 | 34 | 172572 | |||
| 2023-02-01 | SC 13G/A | us74006w1080_020123.txt | 0001306550-23-006397 | 005-92098 | 23577612 | 34 | 13106 | |||
| 2023-01-25 | SC 13G | d9929037_13g.htm | 0000919574-23-000469 | 005-92098 | 23552464 | 34 | 152919 | |||
| 2023-01-17 | 4 | FORM 4 | 0001689548-23-000028 | 5443 | ||||||
| 2023-01-17 | 4 | FORM 4 | 0001689548-23-000027 | 5432 | ||||||
| 2023-01-17 | 4 | FORM 4 | 0001689548-23-000026 | 5421 | ||||||
| 2023-01-17 | 4 | FORM 4 | 0001689548-23-000025 | 5416 | ||||||
| 2023-01-17 | 4 | FORM 4 | 0001689548-23-000024 | 5441 | ||||||
| 2023-01-13 | 4 | FORM 4 | 0001689548-23-000018 | 5339 | ||||||
| 2023-01-13 | 4 | FORM 4 | 0001689548-23-000017 | 5320 | ||||||
| 2023-01-13 | 4 | FORM 4 | 0001689548-23-000016 | 5329 | ||||||
| 2023-01-13 | 4 | FORM 4 | 0001689548-23-000015 | 5342 | ||||||
| 2023-01-13 | 4 | FORM 4 | 0001689548-23-000014 | 5315 | ||||||
| 2023-01-09 | 4 | FORM 4 | 0001689548-23-000008 | 4717 | ||||||
| 2023-01-09 | 4 | FORM 4 | 0001689548-23-000007 | 4701 | ||||||
| 2023-01-09 | 4 | FORM 4 | 0001689548-23-000006 | 4728 | ||||||
| 2023-01-09 | 4 | FORM 4 | 0001689548-23-000005 | 4728 | ||||||
| 2022-11-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0001689548-22-000134 | 001-39620 | 221421128 | 34 | 6102547 | 1 | 1 |
| 2022-11-21 | 4 | FORM 4 | 0001689548-22-000131 | 4726 | ||||||
| 2022-11-21 | 4 | FORM 4 | 0001689548-22-000129 | 4744 | ||||||
| 2022-11-21 | 4 | FORM 4 | 0001689548-22-000127 | 4719 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0001689548-22-000125 | 001-39620 | 221372557 | 34 | 4769008 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-22-000124 | 001-39620 | 221372464 | 34 | 6092243 | 1 | 1 |
| 2022-10-11 | SC 13G/A | Praxis_Precision.txt | 0000093751-22-000608 | 005-92098 | 221303570 | 34 | 8353 | |||
| 2022-09-07 | 8-K | 8-K | 8.01 | 0001689548-22-000118 | 001-39620 | 221229936 | 34 | 180107 | 1 | 1 |
| 2022-08-12 | 8-K | 8-K | 5.02,9.01 | 0001689548-22-000113 | 001-39620 | 221160631 | 34 | 185916 | 1 | 1 |
| 2022-08-08 | 10-Q | 10-Q | 0001689548-22-000111 | 001-39620 | 221144382 | 34 | 5220872 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-22-000110 | 001-39620 | 221144285 | 34 | 4673653 | 1 | 1 |
| 2022-07-26 | 8-K | 8-K | 5.02,9.01 | 0001689548-22-000099 | 001-39620 | 221107457 | 34 | 227656 | 1 | 1 |
| 2022-07-11 | 8-K/A | 8-K/A | 5.02 | 0001689548-22-000096 | 001-39620 | 221077327 | 34 | 177059 | 1 | 1 |
| 2022-07-11 | SC 13G | PRAXIS_PRECISION_MED_INC.txt | 0000093751-22-000573 | 005-92098 | 221076547 | 34 | 10243 | |||
| 2022-07-11 | SC 13G/A | filing.txt | 0000315066-22-001660 | 005-92098 | 221075944 | 34 | 7961 | |||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000094 | 5439 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000093 | 5427 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000092 | 5411 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000091 | 5412 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000090 | 5438 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001689548-22-000089 | 5419 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001689548-22-000082 | 4492 | ||||||
| 2022-06-17 | SC 13G | SC 13G | 0001104659-22-072412 | 005-92098 | 221024150 | 34 | 99781 | |||
| 2022-06-14 | 4 | FORM 4 | 0001689548-22-000080 | 4463 | ||||||
| 2022-06-13 | 4 | FORM 4 | 0001689548-22-000078 | 4492 | ||||||
| 2022-06-09 | 4 | FORM 4 | 0001689548-22-000076 | 4993 | ||||||
| 2022-06-09 | 4 | FORM 4 | 0001689548-22-000075 | 4961 | ||||||
| 2022-06-06 | 8-K | 8-K | 8.01 | 0001689548-22-000072 | 001-39620 | 22996717 | 34 | 183450 | 1 | 1 |
| 2022-06-01 | 8-K | 8-K | 5.07 | 0001689548-22-000070 | 001-39620 | 22987903 | 34 | 198213 | 1 | 1 |
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000068 | 5291 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000067 | 5283 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000066 | 5259 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000065 | 5293 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000064 | 5233 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001689548-22-000063 | 5261 | ||||||
| 2022-05-24 | 4 | FORM 4 | 0001689548-22-000056 | 5283 | ||||||
| 2022-05-24 | 3 | FORM 3 | 0001689548-22-000054 | 7447 | ||||||
| 2022-05-23 | DEFA14A | DEFA14A | 0001689548-22-000052 | 001-39620 | 22949712 | 34 | 16837 | |||
| 2022-05-23 | 8-K | 8-K | 5.02 | 0001689548-22-000051 | 001-39620 | 22949710 | 34 | 178685 | 1 | 1 |
| 2022-05-18 | 4 | FORM 4 | 0001689548-22-000048 | 4719 | ||||||
| 2022-05-18 | 4 | FORM 4 | 0001689548-22-000046 | 4747 | ||||||
| 2022-05-18 | 4 | FORM 4 | 0001689548-22-000044 | 4725 | ||||||
| 2022-05-18 | 4 | FORM 4 | 0001689548-22-000042 | 4746 | ||||||
| 2022-05-18 | 4 | FORM 4 | 0001689548-22-000040 | 4735 | ||||||
| 2022-05-09 | 10-Q | 10-Q | 0001689548-22-000038 | 001-39620 | 22904962 | 34 | 4179841 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001689548-22-000037 | 001-39620 | 22904833 | 34 | 7053919 | 1 | 1 |
| 2022-04-29 | 8-K | 8-K | 8.01 | 0001689548-22-000029 | 001-39620 | 22870458 | 34 | 178677 | 1 | 1 |
| 2022-04-27 | 8-K | 8-K | 7.01,9.01 | 0001689548-22-000026 | 001-39620 | 22860269 | 34 | 16912058 | 1 | 1 |
| 2022-04-14 | DEFA14A | DEFA14A | 0001689548-22-000023 | 001-39620 | 22827992 | 34 | 1365355 | |||
| 2022-04-14 | DEF 14A | DEF 14A | 0001689548-22-000022 | 001-39620 | 22827849 | 34 | 2052104 | |||
| 2022-02-28 | S-8 | FORM S-8 | 0001104659-22-028100 | 333-263081 | 22689840 | 33 | 83679 | |||
| 2022-02-28 | 10-K | 10-K | 0001689548-22-000014 | 001-39620 | 22683800 | 34 | 19948606 | 1 | 1 | |
| 2022-02-28 | 8-K | 8-K | 2.02,7.01,9.01 | 0001689548-22-000013 | 001-39620 | 22683756 | 34 | 6295426 | 1 | 1 |
| 2022-02-15 | 4 | FORM 4 | 0001689548-22-000008 | 4718 | ||||||
| 2022-02-15 | 4 | FORM 4 | 0001689548-22-000007 | 4703 | ||||||
| 2022-02-15 | 4 | FORM 4 | 0001689548-22-000006 | 4701 | ||||||
| 2022-02-15 | 4 | FORM 4 | 0001689548-22-000005 | 4729 | ||||||
| 2022-02-14 | SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0000899140-22-000321 | 005-92098 | 22633235 | 34 | 98823 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001580642-22-000832 | 005-92098 | 22627717 | 34 | 55940 | |||
| 2022-02-11 | SC 13G | JANUS HENDERSON GROUP PLC OWNS >5% | 0001274173-22-000065 | 005-92098 | 22621047 | 34 | 10509 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001193125-22-035552 | 005-92098 | 22616546 | 34 | 206957 | |||
| 2022-02-10 | SC 13G | SCHEDULE 13G | 0001104659-22-018362 | 005-92098 | 22610616 | 34 | 12932 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001319 | 005-92098 | 22604788 | 34 | 8397 | |||
| 2022-02-04 | SC 13G | us74006w1080_020422.txt | 0000834237-22-007265 | 005-92098 | 22593482 | 34 | 13274 | |||
| 2022-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-003164 | 7614 | ||||||
| 2022-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-003163 | 7600 | ||||||
| 2022-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-003162 | 7600 | ||||||
| 2022-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-003160 | 7600 | ||||||
| 2022-01-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-003158 | 7628 |
One latest value per concept from companyfacts (251 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 27.95M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 883.20M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 16.99M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.02M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 55.53M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 8.71M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 35.71 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001689548-26-000039 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 15.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 36.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.32M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -5.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 2.68B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 493,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | USD | 950,000 | 2020-10-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 14.89M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 229,000 | 2021-04-01 | 2021-06-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 43.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 2.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | Assets | Assets | USD | 1.31B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 762.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 986.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 173,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 39.05M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 540.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 383.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 239.64M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001689548-25-000111 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 117.63M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001689548-25-000111 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 924.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 110,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001689548-26-000083 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 361.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 62.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -165.46M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001689548-21-000042 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 1.30B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 361.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 4.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 6.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 150.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 27.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 27.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 15,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -276.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 25.07M | 2020-10-20 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 | |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 471,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 471,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-04 | 0001689548-25-000092 |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 39.05M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | USD | 31.67M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 878.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 213 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 23,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 306.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 59.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 23,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 170.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 657.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 649.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 515.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 7.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 44.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 30.58M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 9.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 4.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 306.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | Depreciation | Depreciation | USD | 105,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | DividendsStock | Dividends, Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -9.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.71 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001689548-21-000042 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -9.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.245 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.032 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.026 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | -3.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | 0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | 0.002 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.039 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 75.20M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 | |
| us-gaap | ForeignCurrencyTransactionLossBeforeTax | Foreign Currency Transaction Loss, before Tax | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 98.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization | Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization | USD | 3.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | HostingArrangementServiceContractImplementationCostExpenseAmortization | Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -302.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -302.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 42,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 224,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 471,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 224,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 74.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -63.59M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 7,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 65,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 417,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 12.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -9.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 1.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -804,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -5,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 6.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | IncreaseInCarryingAmountOfRedeemablePreferredStock | Increase in Carrying Amount of Redeemable Preferred Stock | USD | 493,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 773,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001689548-26-000083 | |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 957,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 134,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.09 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 110,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 110,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 110,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 110,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 110,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | Liabilities | Liabilities | USD | 52.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.31B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 52.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 568.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 383.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 540.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 614.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -365.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -245.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -270.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -167.06M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 39.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 309.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -309.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 1.40M | 2026-03-01 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 732,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 674,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 843,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.09 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 5.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 6.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 3,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -6.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 7,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 39.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | -2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001689548-24-000101 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 4.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock | Payments for Repurchase of Redeemable Convertible Preferred Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 13.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 720.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | PaymentsToDevelopSoftware | Payments to Develop Software | USD | 773,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001689548-26-000083 |
| us-gaap | PreferredStockAmountOfPreferredDividendsInArrears | Preferred Stock, Amount of Preferred Dividends in Arrears | USD | 7.80M | 2020-09-30 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 17.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 13.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 2.40B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 361.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 7.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | RedeemablePreferredStockDividends | Redeemable Preferred Stock Dividends | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 211.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 416,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 600,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 1.00M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001689548-24-000034 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.41B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 7.00M | 2021-11-04 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 391,997 | 2021-11-04 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 43.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 8.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.801 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.881 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.857 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.039 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.009 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.004 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 277.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 102.51 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 27.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 9,929 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 109,647 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 207.72 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 378.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 103.06 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 378.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 103.06 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 0.03 | 2021-11-03 | 2022 | FY | 10-K | 2023-02-07 | 0001689548-23-000044 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 66 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 73.51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 292.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.26B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.067 | 2023-11-28 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001689548-24-000101 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 98.41M | 2021-04-01 | 2021-06-30 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 102,607 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 233.18M | 2020-10-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 809,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 1.74M | 2024-10-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001689548-25-000040 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0001689548-22-000038 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1.42M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 8.05M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-23 | 0001193125-20-301222 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 |
| us-gaap | TemporaryEquityAggregateAmountOfRedemptionRequirement | Temporary Equity, Aggregate Amount of Redemption Requirement | USD | 121.12M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 121.12M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | TemporaryEquityDividendsAdjustment | Temporary Equity, Dividends, Adjustment | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001689548-21-000094 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 121.12M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 53.64M | 2020-10-20 | 2021 | FY | 10-K | 2022-02-28 | 0001689548-22-000014 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 35.46M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 35.46M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-17 | 0001689548-21-000016 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 | |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-08 | 0001689548-22-000111 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -86,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001689548-21-000042 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 88.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 51,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001689548-26-000029 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 29.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 38.47M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001689548-21-000042 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 29.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001689548-26-000089 |